SUMMARY
TrialScope Disclose includes a set of standard assessment and due date rules that can be enabled/disabled which help customers comply with their obligation to disclose clinical trial information.
For IRAN (Iran), TrialScope Disclose includes the following rules:
Assess if Protocol Registration is needed on IRCT (Iran)
Initial Protocol Law Due Date on IRCT (Iran)
Assessments
Assess if Protocol Registration is needed on IRCT (Iran)
Automatically assess Protocol Registration for IRCT for interventional trials conducted in Hong Kong that have started on or after December 4, 2008.
Compliance Events & Due Dates
Initial Protocol Law Due Date on IRCT (Iran)
IRCT (Iran) Protocol Registration is assessed, disclosure needs to be posted on IRCT 1 day prior to study start date.
Protocol Disclosure Due date for “Law” will be set to Study Start Date – 1 Day.